Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Related Citations for PubMed (Select 9179563)

2.
3.

Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon in benign prostatic hyperplasia.

Vacherot F, Azzouz M, Gil-Diez-De-Medina S, Colombel M, De La Taille A, Lefrère Belda MA, Abbou CC, Raynaud JP, Chopin DK.

Prostate. 2000 Nov 1;45(3):259-66.

PMID:
11074529
4.

Lipido-sterolic extract of Serenoa repens (LSESr, Permixon) treatment affects human prostate cancer cell membrane organization.

Petrangeli E, Lenti L, Buchetti B, Chinzari P, Sale P, Salvatori L, Ravenna L, Lococo E, Morgante E, Russo A, Frati L, Di Silverio F, Russo MA.

J Cell Physiol. 2009 Apr;219(1):69-76. doi: 10.1002/jcp.21648.

PMID:
19067321
6.

Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon.

Raynaud JP, Cousse H, Martin PM.

J Steroid Biochem Mol Biol. 2002 Oct;82(2-3):233-9.

PMID:
12477490
7.

Effect of Serenoa repens extract (Permixon) on estradiol/testosterone-induced experimental prostate enlargement in the rat.

Paubert-Braquet M, Richardson FO, Servent-Saez N, Gordon WC, Monge MC, Bazan NG, Authie D, Braquet P.

Pharmacol Res. 1996 Sep-Oct;34(3-4):171-9.

PMID:
9051712
8.

In vivo effect of the lipido-sterolic extract of Serenoa repens (Permixon) on mast cell accumulation and glandular epithelium trophism in the rat prostate.

Mitropoulos D, Kyroudi A, Zervas A, Papadoukakis S, Giannopoulos A, Kittas C, Karayannacos P.

World J Urol. 2002 Apr;19(6):457-61.

PMID:
12022715
9.

Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.

Di Silverio F, Monti S, Sciarra A, Varasano PA, Martini C, Lanzara S, D'Eramo G, Di Nicola S, Toscano V.

Prostate. 1998 Oct 1;37(2):77-83.

PMID:
9759701
10.
11.

Pharmacological effects of the lipidosterolic extract of Serenoa repens (Permixon) on rat prostate hyperplasia induced by hyperprolactinemia: comparison with finasteride.

Van Coppenolle F, Le Bourhis X, Carpentier F, Delaby G, Cousse H, Raynaud JP, Dupouy JP, Prevarskaya N.

Prostate. 2000 Apr 1;43(1):49-58.

PMID:
10725865
12.

Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.

Debruyne F, Koch G, Boyle P, Da Silva FC, Gillenwater JG, Hamdy FC, Perrin P, Teillac P, Vela-Navarrete R, Raynaud JP.

Eur Urol. 2002 May;41(5):497-506; discussion 506-7.

PMID:
12074791
13.
15.

Formation of C21 bile acids from plant sterols in the rat.

Boberg KM, Lund E, Olund J, Björkhem I.

J Biol Chem. 1990 May 15;265(14):7967-75.

16.

BPH and inflammation: pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay.

Vela Navarrete R, Garcia Cardoso JV, Barat A, Manzarbeitia F, López Farré A.

Eur Urol. 2003 Nov;44(5):549-55.

PMID:
14572753
19.

Beta-oxidation of medium chain (C8-C14) fatty acids studied in isolated liver cells.

Christensen E, Hagve TA, Grønn M, Christophersen BO.

Biochim Biophys Acta. 1989 Aug 8;1004(2):187-95.

PMID:
2752017
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk